Integrating GLP-1 RAs Into T2DM Treatment

Overview

In this educational initiative, meet 4 patients with type 2 diabetes mellitus. Review the cases and decide which of these patients could benefit from glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy. Then, review the glycemic and extraglycemic effects of GLP-1 RAs and explore strategies for addressing common patient concerns with GLP-1 RA treatment.

Learning Objectives

Upon completion, participants should be able to:

  • Apply current evidence regarding the use of GLP-1 RAs to treatment decisions for patients with T2DM
  • Incorporate interview techniques to guide patient-centered discussions about individuals’ concerns related to GLP-1 RA therapy to maximize treatment adherence and persistence

Additional Information

Partner: 
Med-IQ
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
Course opens: 
12/26/2024
Course expires: 
12/25/2025
Rating: 
0

Accreditation

Available Credit

  • 0.50 AMA PRA Category 1 Credit™

Register/Take course

Please login or register to take this course.

This course is offered through Med-IQ. 

To take this course you will be redirected to Med-IQ’s website. You must login or create an account with Med-IQ in order to complete this activity.